The Accelerated Aging Hypothesis of Parkinson's Disease is not Supported by the Pattern of Orcadian Melatonin Secretion

References

• Armstrong S. M., Redman J. R. Melatonin: a chronobiotic with antiaging properties?. Medical Hypotheses 1991; 34: 300–309
   PubMed Web of Science ®Google Scholar
• Barbeau A. Aging and the extrapyramidal system. Journal of the American Geriatric Society 1973; 21: 145–149
   PubMedGoogle Scholar
• Barbeau A. Etiology of Parkinson's disease: a research strategy. Canadian Journal of Neurological Sciences 1984; 11: 24–28
   PubMedGoogle Scholar
• Berg L. Does Alzheimer's disease represent an exaggeration of normal aging?. Archives of Neurology 1985; 42: 737–739
   PubMedGoogle Scholar
• Brown G. M., Young S. N., Gauthier S., Tsui H., Grota L. J. Melatonin in human cerebrospinal fluid in daytime: its origin and variation with age. Life Sciences 1979; 25: 929–936
   PubMed Web of Science ®Google Scholar
• Bugiani O., Salvarani S., Perdelli F., Mancardi G. L., Leonardi A. Nerve cell loss with aging in the putamen. European Neurology 1978; 17: 286–295
   PubMedGoogle Scholar
• Calne D. B., Langston J. W. Aetiology of Parkinson's disease. Lancet 1983; 2: 1457–1459
   PubMedGoogle Scholar
• Carlsson A., Winblad B. Influence of age and time interval between death and autopsy on dopamine and 3-mefhoxytyramine levels in human basal ganglia. Journal of Neural Transmission 1976; 38: 271–276
   PubMed Web of Science ®Google Scholar
• Coleman P. D., Flood D. G. Neuron numbers and endritic extent in normal aging and Alzheimer's disease. Neurobiology of Aging 1987; 8: 521–545
   PubMed Web of Science ®Google Scholar
• Critchley M. The neurology of old age. Lancet 1931; 2: 1119–1127; 1221–1230; 1331–1336
   Google Scholar
• Fertl E., Auff E., Doppelbauer A., Waldhauser F. Circadian secretion pattern of melatonin in de novo Parkinsonian patients: evidence for phase shifting properties of L-dopa. Journal of Neural Transmission 1993; 5: 227–234
   Web of Science ®Google Scholar
• Finch C. E. Catecholamine metabolism in the brains of aging male mice. Brain Research 1973; 52: 271–276
   Google Scholar
• Gupta M., Gupta B. K., Thomas R., Bruemmer V., Sladek J. R., Felten D. L. Aged mice are more sensitive to l-methyl-4-phenyl, 1,2,3,6-tetrahydropyridine treatment than young adults. Brain Research 1986; 70: 326–331
   Google Scholar
• Jarvis M. F., Wagner G. C. Age-dependent effects of l-methyl-4-phenyl-l,2,3, 6-tetrahydropyridine (MPTP). Neuropharmacology 1985; 24: 581–583
   PubMedGoogle Scholar
• Gibb W. R. G., Lees A. J. The progression of idiopathic Parkinson's disease is not explained by age-related changes. Clinical and pathological comparisons with post-encephalitic parkinsonian syndrome. Acta Neuropathologia 1987; 73: 195–201
   PubMedGoogle Scholar
• Granerus A. K., Carisson A., Svanborg A. The aging neuron-influence on symptomatology and therapeutic response in Parkinson's syndrome. Advances in neurology, L. J. Poirier, T. L. Sourkes, P. J. Bedard. Raven Press, New York 1979; vol. 24: 327–334
   Google Scholar
• Kloeden P. E., Rossler R., Rossler O. E. Does a centralized clock for ageing exist?. Gerontology 1990; 36: 314–322
   PubMed Web of Science ®Google Scholar
• Koller W., O'Hara R., Weiner W., Lang A., Nutt J., Agid Y., Bonnet A. M., Jankovic J. Relationship of aging to Parkinson's disease. Advances in Neurology, M. D. Yahr, K. J. Bergman. Raven Press, New York 1986; vol. 45: 317–321
   Google Scholar
• Mann D. M. A., Yates P. O. Pathogenesis of Parkinson's disease. Archives of Neurology 1982; 39: 545–549
   PubMedGoogle Scholar
• Martin P. R., Higa S., Burns R. S., Tamarkin L., Ebert M. H., Markey S. P. Decreased 6-hydroxymelatonin excretion in Korsakoff's psychosis. Neurology 1984; 34: 966–968
   PubMedGoogle Scholar
• McGeer P. L., McGeer E. G., Suzuki J. S. Aging and extrapyramidal function. Archives of Neurology 1977; 34: 33–35
   PubMed Web of Science ®Google Scholar
• Nair N. P. V., Hariharasubramanian M., Pilapil C., Isaac I., Thavunday J. X. Plasma melatonin–an index of brain aging in humans?. Biological Psychiatry 1986a; 21: 141–150
   PubMed Web of Science ®Google Scholar
• Nair N. P. V., Hariharasubramanian N., Pilapil C., Thavunday J. X. Plasma melatonin rhythm in normal aging and Alzheimer's disease. Journal of Neural Transmission 1986b; 21: 494, suppl
   Google Scholar
• Newman R. P., LeWitt P. A., Jaffe M., Calne D. B., Larsen T. A. Motor function in the normal aging population. Treatment with levodopa. Neurology 1985; 35: 571–573
   PubMed Web of Science ®Google Scholar
• Nutt J. G., Hammerstad J. P., Gancher S. T. Parkinson's disease-100 maxims. Edward Arnold, London 1992; 14–15
   Google Scholar
• Pierpaoli W. The pineal gland: a circadian or seasonal aging clock?. Aging 1991; 3: 99–101
   PubMedGoogle Scholar
• Pierpaoli W., Dall'ara A., Pedrinis E., Regelson W. The pineal control of aging: the effects of melatonin and pineal grafting on the survival of older mice. Annals of the New York Academy of Sciences 1991; 621: 291–313
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effects. Immunology Letters 1987; 16: 355–362
   PubMed Web of Science ®Google Scholar
• Ricaurte G. A., Irwin I., Forno L. S., DeLanney L. E., Langston E. B., Langston J. W. Aging and MPTP induced degeneration of dopaminergic neurons in the substantia nigra. Brain Research 1987; 403: 43–51
   PubMed Web of Science ®Google Scholar
• Riederer P., Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease. Journal of Neural Transmission 1976; 38: 277–301
   PubMed Web of Science ®Google Scholar
• Rozenchwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J., Erb D. L., Vollmer W. M., Singer C. M. Human melatonin production decreases with age. Journal of Pineal Research 1986; 3: 379–388
   PubMed Web of Science ®Google Scholar
• Sandyk R. Possible role of pineal melatonin in the mechanisms of aging. International Journal of Neuroscience 1990; 52: 85–92
   PubMed Web of Science ®Google Scholar
• Schmid H. A. Decreased melatonin biosynthesis, calcium flux, pineal gland calcification and aging: a hypothetical framework. Gerontology 1993; 39: 189–199
   PubMed Web of Science ®Google Scholar
• Skene D. J., Vivien-Roels B., Sparks D. L., Hunsaker J. C., Pevet P., Ravid D., Swaab D. F. Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease. Brain Research 1990; 528: 170–174
   PubMed Web of Science ®Google Scholar
• Teravainen H., Ward C., Calne D. B. Parkinsonism: current problems and future research. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Kent 1981; 356–367
   Google Scholar
• Thomas D. R., Miles A. Melatonin secretion and age. Biological Psychiatry 1989; 25: 363–369
   Web of Science ®Google Scholar
• Trentini G. P., De Gaetani C., Criscuolo M. Pineal gland and aging. Aging 1991; 3: 103–116
   PubMedGoogle Scholar
• Wisniewski H. M. Clinical, pathological and biochemical aspects of Alzheimer's disease. Advances in behavioral biology: alzheimer's and parkinson's diseases, A. Fisher, I. Hanin, C. Lachman. Plenum Press, New York 1986; vol. 29: 25–36
   Google Scholar
• Wong D. F., Wagner H. N., Dannals N. E. Effects of age on dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science 1984; 226: 1393–1396
   PubMed Web of Science ®Google Scholar